Technetium-99m-MIBI in primary and recurrent head and neck tumors: Contribution of bone SPECT image fusion

Journal of Nuclear Medicine

Volumn 39, Issue 7, 1998, Pages 1166-1171

  Leitha, Thomas ^a   Glaser, Christoph ^a   Pruckmayer, Martha ^a   Rasse, Michael ^a   Millesi, Werner ^a   Lang, Susanna ^a   Nasel, Christian ^a   Backfrieder, Werner ^a   Kainberger, Franz ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bone scan; Head and neck cancer; Image fusion; Staging; Technetium 99m hexakis 2 methoxyisobutyl isonitrile

Indexed keywords

2,3 DICARBOXYPROPANE 1,1 DIPHOSPHONATE TECHNETIUM TC 99M; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NONIONIC CONTRAST MEDIUM;

ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; BONE METABOLISM; BONE SCINTISCANNING; CANCER STAGING; CLINICAL PROTOCOL; COLLIMATOR; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HEAD AND NECK TUMOR; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RECURRENT CANCER; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SQUAMOUS CELL CARCINOMA;

BONE NEOPLASMS; CARCINOMA, ADENOID CYSTIC; CARCINOMA, SQUAMOUS CELL; DIPHOSPHONATES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ORGANOTECHNETIUM COMPOUNDS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031841729     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Silverberg E, Lubera J. Cancer statistics. CA Cancer J Clin 1987;37:2-19.
2. Dillon WP, Harnsberger HR. The impact of radiologic imaging on staging of cancer of the head and neck. Semin Oncol 1991;18:64-79.
3. Mc Guirt WF, Matthews B, Koufman JA. Multiple simultaneous tumors in patients with head and neck cancer. Cancer 1982;50:1195-1199.
4. Harnsberger HR. Handbook of head and neck imaging, 2nd ed. St. Louis, MO: Mosby; 1995.
5. Olmi O, Fallai C, Colagrande S, Giannardi G. Staging and follow-up of nasopharyngeal carcinoma: magnetic resonance imaging versus computerized tomography, Int J Radiat Oncol Biol Phys 1995;32:798-800.
6. Tan EL, Chua SL, Kwok R. Use of magnetic resonance imaging in the evaluation of nasopharyngeal cancer. Ann Acad Med Singapore 1993;22:720-723.
7. Madison MT, Remley and staging of head and neck squamous cell carcinoma. Radiol Clin North Am 1994;32:163-181.
8. Laubenbacher C, Saumweber D, Wagner-Manslau C, et al. Comparison of flourine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 1995;36:1747-1757.
9. 18F]fluoro-D-glucose PET and MR imaging diagnoses. Radiology 1996;200:135-141.
10. 18F]fluoro-2-deoxy-D-glucose. Radiology 1995;197:205-211.
11. Fukumoto M, Yoshida S, Yoshida D, Kishimoto S, Dual-isotope SPECT of skull-base invasion of head and neck tumors. J Nucl Med 1995;36:1740-1746.
12. 67Ga imaging in untreated primary and secondary malignant tumors of the head and neck. Clin Nucl Med 1983;8:107-111.
13. Arbab AS, Koizumi K, Toyama K, Araki T. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. J Nucl Med 1996;37: 1551-1556.
14. Piwnica-Worms D, Rao VV, Kronauge JF, Croop JM. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation. Biochemistry 1995;34:12210-12220.
15. Maublant J, de-Latour M, Mestas D, et al. Technetium-99m-sestamibi uptake in breast tumor and associated lymph nodes. J Nucl Med 1996;37:922-925.
16. 99mTc-methoxyisobutylisonitrile SPECT. Nucl Med Commun 1993; 14:41-46.
17. American Joint Committee on Cancer. Head and neck sites: lip and oral cavity. Manual for staging of cancer, 2nd ed. Philadelphia: JB Lippincott; 1983:25-183.
18. Staudenherz A, Abela C, Niederle B, et al. Comparison and histopathological correlation of three parathyroid imaging methods in a population with ah high prevalence of concomitant thyroid disease. Eur J Nucl Med 1997;24:143-149.
19. Kostakoglu L, Uysal U, Özyae E, et al. Pre-and post-therapy thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma. J Nucl Med 1996; 37:1956-1962.
20. Fischer-Barndies E, Seifert C. Bone scintigraphy: an aid in deciding on the extent of bone resection in malignant oral tumors. J Oral Maxillofac Surg 1995;53:768-770.
21. 99mTc-sestamibi in the assessment of osseous tumor spread. J Nucl Med 1996;37:1526-1528.
22. 67Ga. Clin Nucl Med 1994;19:1063-1065.
23. Baillet G, Albuquerque L, Chen Q, Poisson M, Delattre JY. Evaluation of single.photon emission tomography imaging of supratentorial brain gliomas with technetium-99m sestamibi. E J Nucl Med 1994;21:1061-1066.
24. 99mTc-sestamibi scintimammography. Radiology 1997; 202:421-429.
25. Sutter CW, Stadalnik RC. Noncardiac uptake of technetium-99m-sestamibi: an updated gamut. Semin Nucl Med 1966;2:135-140.
26. Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, Holman L, Davison A, Jones AG. Uptake of the cation hexakis(2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res 1990;50:2198-2202.